« Back
Home /
Apolipoprotein B

Apolipoprotein B

Item no.	20-511-241977
Manufacturer	GENWAY
Amount	1 mg
Category	Metabolism Glucose Homeostasis Cholesterol & Lipid Metabolism Antibodies Obesity Lipid & Fatty Acid Transport Primary Antibodies
Type	Antibody
Clone	057-10035
Specific against	other
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-AFC977
Similar products	20-511-241977
Available
Genway ID:	GWB-AFC977
Isotype:	IgG2b. k
Clone:	057-10035Host Animal: Mouse
Specificity:	Apolipoprotein B (Apo B)
Type of Product:	Monoclonal Antibodies to Lipoproteins
Concentration:	4. 34mg/ml (OD280nm E0. 1% = 1. 4)Preservatives: NaN3
Buffer:	10mM Phosphate pH 7. 4 containing 150mM Sodium ChlorideApplications Notes : Specific methodologies have not been tested using this product.
Warning:	This product contains sodium azide which has been classified as Xn (Harmful) in European Directive 67/548/EEC in the concentration range of 0. 1â ??1. 0%. When disposing of this reagent through lead or copper plumbing flush with copious volumes of water to prevent azide build-up in drains. MAb to Apolipoprotein B. Monoclonal Antibody to Apolipoprotein B (Apo B)
Function:	Apolipoprotein B is a major protein constituent of chylomicrons (apo B-48) LDL (apo B-100) and VLDL (apo B-100). Apo B-100 functions as a recognition signal for the cellular binding and internalization of LDL particles by the apoB/E receptor.
Subcellular Location:	Secreted.
Ptm:	Palmitoylated; structural requirement for proper assembly of the hydrophobic core of the lipoprotein particle. Rna Editing: Modified_positions=2180; Note=The stop codon (UAA) at position 2180 is created by RNA editing. Apo B-48 derived from the fully edited RNA is produced only in the intestine and is found in chylomicrons. Apo B-48 is a shortened form of apo B-100 which lacks the LDL-receptor region. The unedited version (apo B-100) is produced by the liver and is found in the VLDL and LDL.
Disease:	Defects in APOB are a cause of familial hypobetalipoproteinemia (FHBL) [MIM:107730]. FHBL is a genetically heterogeneous autosomal co-dominant disorder associated with reduced plasma concentrations of apoB LDL and VLDL. Heterozygotes for FHBL are usually asymptomatic with LDL cholesterol and apoB-100 concentrations less than 50% of those in normal plasma. Homozygotes have extremely low plasma LDL cholesterol and apoB-100 concentrations and clinical presentation may vary from no symptoms to severe gastrointestinal and neurological dysfunction similar to abetalipoproteinemia [MIM:200100].
Disease:	Defects in APOB are a cause of familial ligand-defective apolipoprotein B-100 (FDB) [MIM:144010]. FDB is a dominantly inherited disorder of lipoprotein metabolism leading to hypercholesterolemia and increased proneness to coronary artery disease (CAD). The plasma cholesterol levels are dramatically elevated due to impaired clearance of LDL particles by defective APOB/E receptors.
Disease:	Defects in APOB associated with defects in other genes (polygenic) can contribute to hypocholesterolemia.
Similarity:	Contains 1 vitellogenin domain.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 8/28/2025

Express Delivery: Save 8 days

Compare

Add to wishlist

Get an offer